203 related articles for article (PubMed ID: 22321053)
1. Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation.
Kekre N; Christou G; Mallick R; Tokessy M; Tinmouth A; Tay J; Allan DS
Transfusion; 2012 Sep; 52(9):2049-54. PubMed ID: 22321053
[TBL] [Abstract][Full Text] [Related]
2. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
[TBL] [Abstract][Full Text] [Related]
3. Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation.
Kekre N; Chou A; Tokessey M; Doucette S; Tinmouth A; Tay J; Allan DS
Transfusion; 2011 Nov; 51(11):2488-94. PubMed ID: 21569047
[TBL] [Abstract][Full Text] [Related]
4. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation.
Perseghin P; Balduzzi A; Galimberti S; Dassi M; Baldini V; Valsecchi MG; Pioltelli P; Bonanomi S; Faccini P; Rovelli A; Pogliani EM; Uderzo C
Bone Marrow Transplant; 2003 Jul; 32(2):231-6. PubMed ID: 12838290
[TBL] [Abstract][Full Text] [Related]
6. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
[TBL] [Abstract][Full Text] [Related]
7. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
9. Coagulation defects do not predict blood product requirements during liver transplantation.
Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
[TBL] [Abstract][Full Text] [Related]
10. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
11. Hb content-based transfusion policy successfully reduces the number of RBC units transfused.
Arslan O; Toprak S; Arat M; Kayalak Y
Transfusion; 2004 Apr; 44(4):485-8. PubMed ID: 15043562
[TBL] [Abstract][Full Text] [Related]
12. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Karanes C; Wang S
Transfusion; 2020 Oct; 60(10):2225-2242. PubMed ID: 32743866
[TBL] [Abstract][Full Text] [Related]
15. Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients.
Howard-Quijano K; Schwarzenberger JC; Scovotti JC; Alejos A; Ngo J; Gornbein J; Mahajan A
Anesth Analg; 2013 Jun; 116(6):1295-308. PubMed ID: 23558832
[TBL] [Abstract][Full Text] [Related]
16. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.
Edwards J; Morrison C; Mohiuddin M; Tchatalbachev V; Patel C; Schwickerath VL; Menitove JE; Singh G
Transfusion; 2012 Nov; 52(11):2445-51. PubMed ID: 22413968
[TBL] [Abstract][Full Text] [Related]
17. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
19. Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
Worel N; Böhm A; Rabitsch W; Leitner G; Mitterbauer M; Kalhs P; Mayr WR; Schwartz D; Greinix HT
Transfusion; 2012 Jun; 52(6):1348-53. PubMed ID: 22128859
[TBL] [Abstract][Full Text] [Related]
20. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
